2 The abbreviations used are: apo, apolipoprotein; CNS, central nervous system; LpE, apo Econtaining lipoproteins; LRP, low density lipoprotein receptor-related protein; RGC, retinal ganglion cell. . Neurosci. 27:1933Neurosci. 27: -1941. LpE bind to low density lipoprotein receptor-related protein-1 and initiate a signaling pathway that involves activation of protein kinase Cδ and inhibition of the pro-apoptotic glycogen synthase kinase-3ß. We now show that uptake of LpE is not required for the neuroprotection. Experiments with inhibitors of phospholipase Cγ1 and RNAi knock-down studies demonstrate that activation of phospholipase Cγ1 is required for the anti-apoptotic signaling pathway induced by LpE. In addition, the protein phosphatase-2B, calcineurin, is involved in a neuronal death pathway induced by removal of trophic additives, and LpE inhibit calcineurin activation. LpE also attenuate neuronal death caused by oxidative stress. Moreover, physiologically-relevant apo E3-containing lipoproteins generated by apo E3 knock-in mouse astrocytes more effectively protect neurons from apoptosis than do apo E4-containing lipoproteins. Since inheritance of the apo E4 allele is the strongest known genetic risk factor for Alzheimer disease, the reduced neuroprotection afforded by apo E4-containing LpE might contribute to the neurodegeneration characteristic of this disease.
The lipoprotein composition of cerebrospinal fluid differs from that of plasma because the blood-brain barrier prevents the movement of lipoproteins from the peripheral circulation into the central nervous system (CNS 2 ) (1). The CNS contains a distinct population of lipoprotein particles that are generated within the CNS and are thought to play important roles in the metabolism and transport of lipids within the brain. These lipoproteins are the size and density of plasma high density lipoproteins and contain apolipoprotein (apo) E and apo J as their major protein constituents (2) (3) (4) (5) . The apo E-containing lipoproteins (LpE) in the CNS are generated by non-neuronal glial cells, primarily astrocytes (5) . Astrocytes are thought to provide nutrient support for neurons by delivering lipoproteins to neurons for axonal growth (6) and synaptogenesis (7) . Interest in the function of apo E in the nervous system has blossomed recently because after nerve injury the synthesis of apo E dramatically increases (by up to 150-fold) (6, 8) . In addition, inheritance of the ε4 allele of apo E, instead of the more common ε3 allele, is the strongest genetic risk factor known for development of late-onset Alzheimer's disease (9, 10) . Furthermore, apo E3-containing lipoproteins have been reported to stimulate axon growth more efficiently than those containing apo E4 (11, 12) . Thus, it has been proposed that LpE assist in repairing neurons after injury.
Our laboratory has reported that astrocyte-derived LpE stimulate axon extension of retinal ganglion cells (RGCs; CNS neurons) by binding to a neuronal receptor of the low density lipoprotein receptor family on axons (13) . Neurons in the CNS express several receptors of this superfamily for which apo E is a ligand (2, 14, 15) . Some of these receptors can function both in the endocytosis of ligands (16) and in signaling pathways that are required for normal brain development (17, 18) . Recently, we demonstrated that glia-derived LpE strikingly protect cultured RGCs from apoptosis induced by withdrawal of trophic additives (19) . The prevention of neuronal apoptosis was promoted by LpE binding to the multifunctional low density lipoprotein receptor-related protein-1 (LRP1) whereupon a signaling pathway was initiated that involved activation of protein kinase Cδ and inactivation of the proapoptotic kinase, glycogen synthase kinase-3ß (19) .
The aim of the present study was to dissect further the mechanism by which LpE protect RGC from apoptosis. We demonstrate that uptake of LpE is not required for the prevention of apoptosis. Furthermore, a signaling pathway induced upon binding of LpE to LRP1 requires the action of phospholipase Cγ1 upstream of protein kinase Cδ. Our data also show that glial LpE containing apo E3 are more protective against apoptosis than are apo E4-containing lipoproteins.
MATERIALS AND METHODS

Materials.
FK506, deltamethrin, cytochalasin D and U73122 were purchased from Sigma (St. Louis, MO). Two-day-old Sprague-Dawley rats were used for isolation of glial cells. Colonies of mice lacking endogenous apo E but expressing human apo E3 or human apo E4 [B6.Cg-Tg(GFAP-APOE3)37Hol Apoe tm1Unc /J and B6.CgTg(GFAP-APOE4)1Hol
Apoe tm1Unc /J, respectively], were established at the University of Alberta from breeding pairs of mice obtained from Jackson Laboratories (Bar Harbor, ME).
Preparation of retinal ganglion cells (RGCs).
RGCs were cultured according to the method of Barres et al. (20) with minor modifications. Briefly, retinae were isolated from 2-day-old Sprague Dawley rats and digested with papain (16.5 units/ml) for 15 min at 37 o C. The retinae were triturated in phosphate-buffered saline containing 0.15% (w/v) trypsin inhibitor (Roche Applied Science, Mannheim, Germany) and 0.15% (w/v) bovine serum albumin (Sigma). The retinal cell suspension was incubated with anti-macrophage antiserum (Accurate Chemical and Scientific Corp., Westbury, NY) for 10 min at room temperature. The suspension was centrifuged for 5 min at 200 x g, after which cells were re-suspended in phosphate-buffered saline containing 1% (w/v) trypsin inhibitor and 1% (w/v) bovine serum albumin. The preparation was centrifuged then re-suspended in phosphate-buffered saline containing 0.02% bovine serum albumin and 5 µg/ml insulin. The cells were incubated on a panning plate (150 mm Petri dish) coated with goat antirabbit IgG (Pierce Biotechnology, Rockford, IL) for 30 to 40 min at room temperature. Non-adherent cells were filtered through a 20 µm Nitex filter (SEFAR America, Ltd., Kansas City, MO) and incubated for 45 to 60 min on a second panning plate (100 mm Petri dish) coated with goat anti-mouse IgMµ (Pierce Biotechnology) and mouse anti-Thy1.1 antibodies secreted from T11D7e2 cells (American Type Culture Collection, Manassas, VA). The plate was washed with phosphate-buffered saline then adherent cells (the RGCs) were released by treatment with 0.125% (w/v) trypsin for 8 min at 37 o C. The neuronal suspension was mixed with 30% fetal bovine serum in Neurobasal medium (Invitrogen, Carlsbad, CA) and centrifuged at 200 x g for 5 min. The neurons were re-suspended in basal medium containing trophic additives: basal medium contains glutamine (1 mM), insulin (5 µg/ml), N-acetylcysteine (5 µg/ml), progesterone (62 ng/ml), putrescine (16 µg/ml), sodium selenite (40 ng/ml), bovine serum albumin (0.1 mg/ml), triiodothyronine (40 ng/ml), transferrin (0.1 mg/ml) and sodium pyruvate (1 mM) in Neurobasal medium; trophic additives are defined as: forskolin (10 µM, Sigma), brain-derived neurotrophic factor (50 ng/ml, PreproTech Inc., Rocky Hill, NJ), ciliary neurotrophic factor (50 ng/ml, PreproTech Inc.), basic fibroblast growth factor (50 ng/ml, PreproTech Inc.) and 2% B27 supplement (Invitrogen). The RGCs were plated on 96-well plates coated with poly D-lysine (Sigma) and laminin (Sigma) (5,000 cells/well).
Isolation and culture of cortical glia. Glial cells were isolated from cerebral cortices of 2-day-old rats or mice according to the method of Gong et al. (21) . Glia were cultured in Dulbecco's-modified Eagle's medium containing 10% fetal bovine serum.
The cultures were highly enriched in astrocytes (13) (see Fig. 1 ).
Isolation of apo E-containing lipoproteins (LpE) from glia-conditioned medium.
Glial cells were washed x 3 with phosphatebuffered saline and cultured for 3 days in basal medium (as used for culture of RGCs) lacking trophic additives. The conditioned medium was collected and centrifuged at room temperature for 10 min at 1,000 x g. The supernatant, designated "gliaconditioned medium", was subjected to ultracentrifugation on a discontinuous sucrose density gradient consisting of sucrose solutions of densities 1.30, 1.20, 1.10 and 1.006 g/ml at 4 o C for 48 h at 160,000 x g in a Beckman SW40-Ti rotor (13) . Fractions were collected from tops of the tubes and immunoblotted for apo E and apo J, as described below. Fractions of densities 1.07 to 1.12 g/ml were combined and concentrated on an Amicon Ultra filter, 100 kDa molecular mass cut-off (Millipore, Bedford, MA). The amount of LpE used in experiments was normalized to equal amounts of cholesterol (1 µg/ml) as measured by gas-liquid chromatography (13) .
Immunoblotting. Proteins in RGCs and isolated lipoproteins were dissolved by boiling the samples for 5 min in buffer containing 62.5 mM Tris-HCl, 10% glycerol, 2% SDS and 5% ß-mercaptoethanol. Proteins were separated by electrophoresis on polyacrylamide gels containing 0.1% SDS, then transferred to polyvinylidene difluoride membranes. The membranes were incubated with 5% non-fat milk in 10 mM Tris-buffered saline containing 0.1% (v/v) Tween 
Induction and detection of apoptosis.
Apoptosis was induced in RGCs by withdrawal of trophic additives (forskolin, brain-derived neurotrophic factor, ciliary neurotrophic factor, basic fibroblast growth factor and B27 supplement) from the culture medium (13, 19 Briefly, 20 µl of 1 M NaHCO 3 were added to 200 µl LpE suspension in phosphatebuffered saline, then mixed with Texas Red dye solution (1.92 µl). The mixture was stirred for 1 h at room temperature in the dark. The Texas Red-labeled LpE were washed twice with phosphate-buffered saline using an Amicon Ultra filter (100 kDa molecular mass cut-off; Millipore).
RNA silencing of phospholipase Cγ1.
Negative control small interfering RNA (siRNA) (AllStars Negative siRNA) and two siRNAs specific for phospholipase Cγ1 (catalog numbers S101961939 and S1011961946) were purchased from Qiagen (Mississauga, ON, Canada). RGCs that had been cultured for 3 to 4 days were transfected with these siRNAs (20 pmol/well) using GeneSilencer siRNA Transfection Reagent (Gene Therapy Systems, San Diego, CA) according to manufacturer's instructions. In brief, the siRNA and GeneSilencer Reagent were mixed for 10 min at room temperature then incubated with RGCs for 24 h. The medium was changed to fresh medium for an additional 24 h, or for 48 h for immunoblotting experiments and assessment of apoptosis.
Lipid composition of glial lipoproteins. Lipids were extracted (22, 23) from lipoproteins (200 µg protein) and analyzed for the mass of unesterified cholesterol and phospholipids (µg/mg protein) by gas-liquid chromatography (19) .
Immunocytochemistry of glia. Glial cells isolated from cerebral cortices were washed x 3 with phosphate-buffered saline, then fixed with 4% paraformaldehyde for 20 min. The cells were permeabilized in 0.2% Triton X-100 for 15 min at 4 o C and blocked with 5% goat serum in phosphate-buffered saline for 1 h. The cells were incubated for 2 h at room temperature with mouse anti-bovine glial fibrillary acidic protein (dilution 1:500, BD Biosciences, Franklin Lake, NJ), rabbit anti-Iba1 (dilution 1:500, Wako, Osaka, Japan), mouse anti-human CNPase (2',3'-cyclic nucleotide 3'-phosphodiesterase; dilution 1:250, Abcam, Cambridge, MA) or mouse anti-rat ßIII tubulin (dilution 1:500, Abcam) in phosphate-buffered saline containing 2% bovine serum albumin. The cells were washed x 3 with phosphatebuffered saline then incubated with Alexa Fluor 488-conjugated goat anti-rabbit IgG (dilution 1:200, Invitrogen) and Alexa Fluor 594-conjugated goat anti-mouse IgG (dilution 1:200, Invitrogen) for 1 h at room temperature. For assessment of cell survival, glia were incubated with Hoechst 33258 (1 µg/ml, Invitrogen) for 15 min at room temperature, washed x 3 with phosphate-buffered saline then mounted with Vectashield (Vector Laboratories, Inc., Burlingame, CA). Photographs were taken using an Olympus IX71 microscope (Tokyo, Japan). The different types of glia were assessed by quantifying the number of stained cells as a percentage of total number of cells. More than 400 cells were counted.
RESULTS
Internalization of glia-derived LpE is not required for protection against apoptosis -
We have previously demonstrated that glia-derived LpE activate an anti-apoptotic signaling pathway in retinal ganglion cells (RGCs) upon binding to the low density lipoprotein receptor-related protein-1 (LRP1) (19) . Since LRP1 can internalize LpE via endocytosis and can also act as a signaling receptor (17,18), we determined whether or not lipoprotein uptake is required for the neuroprotection. Glial cells were isolated from the cerebral cortex of 2-day-old rats (21) and cultured for 3 days in the absence of serum. These cultures contained 82.5% astrocytes, 16% microglia, 0.5% oligodendrocytes and 1% neurons according to staining with fluorescencelabeled antibodies to marker proteins: glial fibrillary acidic protein (astrocytes), Iba1 (microglia), 2',3'-cyclic nucleotide 3'-phosphodiesterase (oligodendrocytes) and ßIII tubulin (neurons) (Figs. 1A,B,C).
The glia-conditioned medium was collected and lipoproteins (density 1.07-1.12 g/ml) were isolated by sucrose density gradient ultracentrifugation (13, 19) . The fractions containing apo E were identified by immunoblotting, then combined and concentrated using a centrifuge filter. The concentrated fraction was designated as LpE. Proteins in glia-conditioned medium and in the LpE-rich fraction were stained with Coomassie blue (Fig. 1D) . Apo E secreted by the glia was highly enriched in the LpE fraction. The LpE were fluorescence-labeled with Texas Red and subsequently incubated with RGCs in the presence or absence of 20 µM cytochalasin D, an agent that induces actin depolymerization and blocks endocytosis (24) . After 3 h, the uptake of fluorescent LpE by RGCs was visualized by fluorescence microscopy. Cytochalasin D markedly reduced the number of fluorescence-positive cells (from 69.0% to 8.0%; Fig. 2A ). Fluorescent LpE also nonspecifically stained cell debris, resulting in the intensely-stained small red dots visible in Fig. 2A . To determine if inhibition of LpE uptake by cytochalasin D abolished the protective effect of LpE, we assessed the number of apoptotic nuclei in RGCs after 24 h by Hoechst staining (19) . Cells with shrunken and fragmented nuclei were counted as apoptotic and the number of apoptotic neurons is expressed as percentage of total number of neurons. We have previously examined apoptosis of RGC under these conditions by both Hoechst staining and by staining with annexin V-fluorescein/propidium iodide (19) . As in our previous studies (19) , removal of trophic additives from the culture medium markedly increased the percentage of apoptotic nuclei (from ~8% to ~70%) (Fig.  2B) . LpE almost completely prevented the neuronal death caused by removal of trophic additives. The presence of cytochalasin D did not reduce the ability of LpE to protect the neurons from apoptosis (Fig. 2B ) despite the finding ( Fig. 2A) (25) . In contrast to the results with H 2 O 2 , exposure of RGCs to tumor necrosis factor-α, an inflammatory mediator, for up to 48 h at concentrations of up to 100 ng/ml did not cause significant neuronal death. Nor did LpE affect survival of RGCs exposed to this agent (data not shown).
Calcineurin participates in neuronal apoptosis induced by withdrawal of trophic additives -In our previous studies we started to define the anti-apoptotic signaling pathway(s) induced in RGCs upon binding of LpE to LRP1. We found that when trophic additives were removed from the culture medium of RGCs, phosphatidylserine became exposed on the cell surface of RGCs and pro-apoptotic caspases were activated (19) . An objective of the present study was to define in more detail the apoptotic pathway(s) that is/are induced in RGCs upon withdrawal of trophic additives. It has been reported that cleavage of the auto-inhibitory domain of the protein phosphatase 2B, calcineurin, is enhanced in some chronic neurodegenerative diseases such as glaucoma (26) . Moreover, the cleaved, active, form of calcineurin leads to apoptosis via a mitochondrial apoptotic pathway (27) (28) (29) (30) . We, therefore, examined the role of calcineurin in neuronal apoptosis caused by removal of trophic additives. A rapid (within ~10 min) and transient cleavage of calcineurin to its active form (~45 kDa) occurred upon withdrawal of trophic additives (Fig. 4A) . Withdrawal of trophic additives from RGCs also caused pronounced neuronal death (Fig. 4B) to an extent (~80%) similar to that shown in Fig.  2B . To determine if calcineurin participated in the apoptotic pathway initiated by removal of trophic additives, we tested whether or not calcineurin inhibitors prevented apoptosis of RGCs. The calcineurin inhibitors, FK506 (1 µM) (31) and deltamethrin (1 µM) (32, 33) were dissolved in dimethylsulfoxide and given to the neurons. Control cells were given an equivalent amount of dimethylsulfoxide (0.4 µl/ml) without inhibitor. Both calcineurin inhibitors prevented apoptosis of RGCs (Fig. 4B) indicating that activation of calcineurin is involved in an apoptotic pathway that is induced upon withdrawal of trophic additives. Furthermore, the amount of active calcineurin in RGCs cultured without trophic additives was reduced by LpE to the same level as in RGCs cultured in the presence of trophic additives (Figs.  4C,D) . Thus, LpE inhibit calcineurin activation, and inhibition of calcineurin prevents neuronal death. Consequently, both the calcineurin pathway and the glycogen synthase kinase-3ß apoptotic pathway are inhibited by LpE.
Phospholipase Cγ1 contributes to the neuroprotection elicited by LpEActivation of protein kinase Cδ occurs during an anti-apoptotic signaling pathway that is activated when LpE binds to LRP1 (19) . Since diacylglycerols activate protein kinase C (34) we hypothesized that generation of diacylglycerols, via hydrolysis of phosphatidylinositol-4,5-bisphosphate by phospholipase C, might contribute to the neuroprotective effect of glial LpE. Removal of trophic additives from RGCs caused extensive neuronal death which was prevented by LpE ( Fig. 5A; also Fig. 2B ). Addition of the phospholipase C inhibitor, U73122 (5 µM), to trophic additive-deprived neurons completely abrogated the antiapoptotic effect of LpE. Importantly, U73122 did not cause death of RGCs that were provided with trophic additives (Fig. 5A) . Thus, phospholipase Cγ1 appears to be involved in the LpE-mediated protection of RGCs from apoptosis.
As an additional indication of the importance of phospholipase Cγ1 in the LpE-mediated survival pathway, we reduced the expression of phospholipase Cγ1 by RNA silencing. RGCs were cultured for 3 to 4 days, then transfected with either a control siRNA, or one of two different siRNAs targeted to phospholipase Cγ1. The RGCs were cultured for 48 h or 72 h after which immunoblotting was performed with antiphospholipase Cγ1 antibodies. Neither of the phospholipase Cγ1 siRNAs reduced the amount of phospholipase Cγ1 protein significantly after 48 h (Fig. 5B) . However, 72 h after transfection with either phospholipase Cγ1-specific siRNA, the amount of phospholipase Cγ1 was significantly reduced (Fig. 5B) . In contrast, none of the siRNAs reduced the amount of the control protein ß-actin (Fig. 5B) . Quantification of immunoblots from 3 independent transfections with each siRNA construct (Figs. 5C,D) revealed that 72 h after transfection the amount of phospholipase Cγ1 protein was reduced by 35 to 50%. To determine whether or not reduction in phospholipase Cγ1 increased neuronal apoptosis, the siRNA-silenced RGCs were cultured with or without trophic additives, and with or without glial LpE. Compared to control siRNA, neither phospholipase Cγ1 siRNA increased the number of apoptotic nuclei in RGCs cultured in the presence of trophic additives (Fig.  5E ). As expected, however, removal of trophic additives from each of the three types of transfected neurons increased the percentage of apoptotic nuclei (from ~20% to ~70%) (Fig. 5E ). Although LpE prevented apoptosis of neurons transfected with control siRNA, the neuroprotection by LpE was abolished in neurons in which phospholipase Cγ1 expression was reduced (Fig. 5E ). These experiments demonstrate that phospholipase Cγ1 provides a neuroprotective signal in the anti-apoptotic pathway initiated by LpE. Because of the established role of phospholipase C in activation of protein kinase C (34), these data suggest that phospholipase Cγ1 acts upstream of protein kinase C in this antiapoptotic pathway.
Apo E4-containing lipoproteins are less neuroprotective than apo E3-containing lipoproteins -
In light of many reports that apo E4 is detrimental for neuronal functions (35-37), we compared the anti-apoptotic activity of glial LpE that contained either human apo E3 or human apo E4. We collected LpE secreted by astrocytes isolated from mice that lacked endogenous mouse apo E but expressed either human apo E3 or apo E4. According to immunoblotting, LpE isolated from astrocyte-conditioned medium contained approximately equal amounts of apo E and also similar amounts of apo J (Fig. 6) . We also analyzed the lipid content of the two types of glial LpE. Although phospholipids comprise the major lipid component of LpE, cholesterol is also abundant ( Table 1) . The lipid content (µg/mg protein) of apo E3-and apo E4-containing lipoproteins was indistinguishable, and was also similar to that of rat glial LpE, although mouse LpE contained more phospholipid relative to cholesterol than did rat LpE ( Table 1 ). The isolated lipoproteins that contained apo E3 or apo E4 were supplied to RGCs from which trophic additives had been withdrawn; control cultures were provided with trophic additives but were not given LpE. The apo E3-containing lipoproteins effectively protected the RGCs from apoptosis whereas the apo E4-containing lipoproteins were significantly less protective (Fig. 6B) .
DISCUSSION
Neuronal apoptosis is a characteristic of neurodegenerative disorders such as Alzheimer disease, Parkinson's disease and Niemann-Pick Type C disease. In the present study we provide novel information on mechanisms by which LpE protect neurons from apoptosis induced by removal of trophic additives. Consistent with our previous observation that LpE promote survival of RGCs (19) , neuronal and behavioural defects have been observed in apo E knock-out mice, particularly after injury (38) and during aging (39, 40) . Thus, the LpEinduced anti-apoptotic signaling pathway that we have identified might protect CNS neurons from apoptosis in some neurodegenerative disorders. Levels of neurotrophic factors such as brain-derived neurotrophic factor are decreased in brains of individuals with Alzheimer disease and Parkinson disease (41)(42). Interestingly, the neuroprotective action of LpE in RGC is not restricted to apoptosis caused by withdrawal of trophic additives since our studies show that neuronal death caused by oxidative stress (exposure to H 2 O 2 ) is also attenuated by LpE.
The presence of apo E on the lipoproteins is necessary for their antiapoptotic properties. Moreover, association of apo E with lipid is required for initiation of the anti-apoptotic signaling pathway, presumably by maintaining an appropriate receptor-binding conformation of the protein (43) . Our data show that cholesterol is not required in LpE for the neuroprotection because reconstituted LpE completely lacking cholesterol effectively prevent apoptosis of RGCs (19) . In addition to receptors of the low density lipoprotein receptor superfamily acting as endocytosis receptors (16) 
Involvement
of calcineurin in neuronal apoptosis -We previously showed that withdrawal of trophic additives caused exposure of phosphatidylserine on the surface of RGCs and that caspases were involved in this apoptotic pathway (19) . We now show that withdrawal of trophic support from RGCs activates calcineurin, a protein phosphatase-2B. We also demonstrate that calcineurin inhibitors prevent the neuronal death. Thus, calcineurin appears to play a role in the apoptotic pathway(s) induced by removal of trophic additives from RGCs. Activation of calcineurin has been reported to induce the dephosphorylation of BAD (a pro-apoptotic member of the Bcl-2 family), and activate caspase-3, thereby causing apoptosis in several types of cells including neurons (27) (28) (29) . Moreover, FK506 and cyclosporine (inhibitors of calcineurin A) block mitochondria-mediated apoptosis in primary cortical neurons (54, 55) and glutamate-induced apoptosis in astrocytes (56) . These data suggest that calcineurin plays an important role in apoptosis in the CNS. We now show that LpE attenuate the activation of calcineurin that occurs upon withdrawal of trophic additives from RGCs, although we cannot distinguish between calcineurin and glycogen synthase kinase-3ß acting in the same, or independent, apoptotic pathways (Fig. 7) . Further details of the link between activation of LRP1 and attenuation of calcineurin activation remain to be established. However, we speculate that reduction in neuronal calcium levels, induced by activation of LRP1, inhibits calcineurin cleavage (57)(58). Moreover, the calcium-dependent cysteine protease, calpain, cleaves full-length calcineurin to the constitutively active form (45 kDa) (59) . Thus, a reduction in intracellular calcium levels induced by activation of LRP1 might prevent apoptosis by inhibiting calcineurin cleavage.
We conclude that LpE protect neurons from death mediated by both the calcineurin pathway and the glycogen synthase kinase-3ß pathway (Fig. 7) . Our observations provide additional support for the idea that calcineurin-mediated apoptosis can be a component in nerve injuries and neurodegenerative diseases (28, 60, 61) (62, 63) .
Apo E isoforms and neuronal apoptosis -Inheritance of the ε4, rather than the more common ε3, allele of apo E is the strongest known genetic risk factor for development of Alzheimer disease (9) . We, therefore, compared the ability of physiologically-relevant apo E3-and apo E4-containing lipoproteins to protect RGCs from apoptosis induced by withdrawal of trophic additives. LpE secreted by astrocytes isolated from mice expressing human apo E3 or apo E4, but lacking endogenous mouse apo E, were given to RGCs. The apo E3-containing lipoproteins protected RGCs from apoptosis whereas the apo E4-containing lipoproteins were significantly less protective (Fig. 6) . To determine if the difference in protection provided by the two types of LpE were due to gross differences in lipid composition of the LpE, we measured the cholesterol and phospholipid content of the LpE and found no significant differences between apo E3-and apo E4-containing LpE. These observations are consistent with our previous observation that reconstituted high density lipoprotein particles that contained only phospholipids and recombinant apo E4 were less neuroprotective for RGCs than were reconstituted apo E3-containing particles (19) . We speculate that the differential protection afforded by apo E3-and apo E4-containing glial lipoproteins might contribute to the extensive neurodegeneration that occurs in late-onset Alzheimer disease patients that express apo E4.
In conclusion, we have demonstrated that LpE protect neurons from apoptosis via a signaling mechanism that does not require internalization of the LpE particles. The signaling pathway that occurs upon the binding of LpE to LRP1 on RGCs involves activation of phospholipase Cγ1 and subsequent activation of protein kinase Cδ. This kinase directly or indirectly phosphorylates and inactivates glycogen synthase kinase-3ß and prevents apoptosis, as proposed in the model depicted in Fig. 7 . Furthermore, withdrawal of trophic additives from RGCs activates a pro-apoptotic pathway that involves calcineurin; this activation is also prevented by LpE (Fig. 7) . Finally, we show that physiologicallyrelevant, astrocyte-derived apo E4-containing lipoproteins are less able to protect neurons from apoptosis than are apo E3-containing lipoproteins. independent experiments. *P < 0.05 for BM(+) versus BM(-).
FIGURE LEGENDS
# P < 0.05 for BM(-) versus BM(-)+LP. Statistical analysis was performed using one-way ANOVA followed by Bonferroni's multiple comparison. . Data are ratios of amounts of PLCγ1:β-actin and are means ± S.E. from 3 independent experiments. *P < 0.05 for Neg versus PLCγ1 siRNA #1.
# P < 0.01 for Neg versus PLCγ1 siRNA #2. (E): RNA silencing of phospholipase Cγ1 blocks the antiapoptotic effect of LpE. RGCs were cultured for 3 to 4 days then transfected with 20 pmol of either a negative control siRNA (Neg) or one of two siRNAs (#1 and #2) specific for phospholipase Cγ1. After 3 days, the RGCs were incubated for 24 h in medium containing [BM(+)] or lacking [BM(-)], trophic additives. Some neurons were given apo E-containing lipoproteins (LP), as indicated. The percentage of neurons with apoptotic nuclei was determined by Hoechst staining. Data are means ± S.E. of 3 independent experiments. *P < 0.0001 for Neg versus #1 or #2. Statistical analysis was performed using one-way ANOVA followed by Bonferroni's multiple comparison. Fig. 6 . ApoE4-containing LpE less effectively protect RGCs against apoptosis than do apoE3-containing LpE. Cortical glia were isolated from mice lacking endogenous apo E but expressing human apo E3 or human apo E4. LpE were isolated from conditioned medium. (A): equal amounts of LpE protein (10 µg) were separated by polyacrylamide gel electrophoresis and immunoblotted with antibodies directed against apo E and apo J. The experiment was repeated two additional times with similar results. (B): LpE secreted by mouse glia expressing human apo E3 or apo E4 were given to RGCs for 24 h in medium lacking trophic additives [BM(-)]. Control cultures were supplied with trophic additives [BM(+)]. The number of apoptotic neurons was determined by Hoechst staining and is given as percentage of total number of neurons. Data are means ± S.E. from 4 independent experiments. *P < 0.005 for BM(-) versus BM(-) + apo E3; and for BM(-) + apo E4.
# P < 0.001 for apo E3 versus apo E4. Statistical analysis was performed using one-way ANOVA followed by Bonferroni's multiple comparison. Fig. 7 . Proposed pathway for protection of RGCs from apoptosis by apo E-containing lipoproteins. Withdrawal of trophic additives from RGCs promotes apoptosis which can be prevented by glia-derived apo E-containing lipoproteins (LP). When LP bind to LRP1, phospholipase Cγ1 (PLCγ1) is activated and hydrolyzes phosphatidylinositol bisphosphate (PIP 2 ) to diacylglycerol (DAG) and inositol trisphosphate (IP 3 ). DAG activates protein kinase Cδ (PKCδ) which, directly or indirectly, phosphorylates and inactivates the pro-apoptotic kinase, glycogen synthase kinase 3ß (GSK3ß). In addition, withdrawal of trophic additives from RGCs induces cleavage/activation of calcineurin and activation of caspases resulting in apoptosis within 24 h. Thus, withdrawal of trophic additives causes neuronal death via a GSK3ß-dependent signaling pathway as well as via a calcineurin-dependent pathway, and both pathways are inhibited by LP.
TABLE 1
Apo E-containing lipoproteins (LpE) were collected from conditioned medium of glia isolated from 2-day-old rats and apo E knock-out mice that expressed human apo E3 (E3 mouse) or apo E4 (E4 mouse) (41) . Lipids were extracted from 200 µg protein that contained equal amounts of apo E3 and apo E4, according to immunoblotting; see Fig. 6 . The mass of cholesterol and phospholipids was quantified by gas-liquid chromatography. Data are means ± S.E. from duplicate analyses of 3 independent lipoprotein preparations. B.
